Clearbridge Health Limited (SGX:1H3)
Singapore
· Delayed Price · Currency is SGD 0.0030
0.00 (0.00%)
At close: Mar 26, 2025
Clearbridge Health Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 9.9 | 11.49 | 16.41 | 11.44 | 36.26 | Upgrade
|
| Revenue Growth (YoY) | -13.81% | -29.99% | 43.44% | -68.44% | 68.38% | Upgrade
|
| Cost of Revenue | 5.16 | 5.4 | 6.84 | 5.08 | 22.44 | Upgrade
|
| Gross Profit | 4.74 | 6.1 | 9.58 | 6.36 | 13.81 | Upgrade
|
| Selling, General & Admin | 5.11 | 6.15 | 6.21 | 6.77 | 7.95 | Upgrade
|
| Other Operating Expenses | 2.32 | 3.32 | 3.81 | 3.23 | 4.71 | Upgrade
|
| Operating Expenses | 8.71 | 10.86 | 11.58 | 11.74 | 17.42 | Upgrade
|
| Operating Income | -3.97 | -4.77 | -2.01 | -5.38 | -3.6 | Upgrade
|
| Interest Expense | -0.68 | -0.76 | -0.87 | -1.72 | -2.33 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.17 | 0.08 | 0.05 | 0.13 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.13 | - | - | - | 0.4 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.37 | -18.76 | 0.28 | -2.88 | 3.06 | Upgrade
|
| EBT Excluding Unusual Items | -4.13 | -24.12 | -2.52 | -9.93 | -2.34 | Upgrade
|
| Impairment of Goodwill | - | -10.37 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -0.15 | -8.77 | -6.62 | 3.31 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | 0.01 | 0.17 | 2.01 | 1.33 | Upgrade
|
| Asset Writedown | -0.02 | - | -0.12 | - | -0.12 | Upgrade
|
| Other Unusual Items | - | 0.27 | - | 0.97 | -0.06 | Upgrade
|
| Pretax Income | -4.14 | -34.37 | -11.24 | -13.57 | 2.12 | Upgrade
|
| Income Tax Expense | 0.07 | -1.9 | 0.19 | 0.32 | 0.04 | Upgrade
|
| Earnings From Continuing Operations | -4.21 | -32.47 | -11.43 | -13.89 | 2.07 | Upgrade
|
| Earnings From Discontinued Operations | 0.11 | - | 1.33 | -3.59 | - | Upgrade
|
| Net Income to Company | -4.1 | -32.47 | -10.09 | -17.48 | 2.07 | Upgrade
|
| Minority Interest in Earnings | 0.49 | 0.27 | -1.05 | -2.49 | -1.46 | Upgrade
|
| Net Income | -3.61 | -32.2 | -11.14 | -19.97 | 0.62 | Upgrade
|
| Net Income to Common | -3.61 | -32.2 | -11.14 | -19.97 | 0.62 | Upgrade
|
| Shares Outstanding (Basic) | 687 | 619 | 618 | 617 | 598 | Upgrade
|
| Shares Outstanding (Diluted) | 687 | 619 | 618 | 617 | 601 | Upgrade
|
| Shares Change (YoY) | 11.07% | 0.14% | 0.12% | 2.75% | 15.05% | Upgrade
|
| EPS (Basic) | -0.01 | -0.05 | -0.02 | -0.03 | 0.00 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.05 | -0.02 | -0.03 | 0.00 | Upgrade
|
| Free Cash Flow | -2.12 | -3.99 | -2.66 | -3.74 | 1.53 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.00 | -0.01 | 0.00 | Upgrade
|
| Gross Margin | 47.88% | 53.05% | 58.35% | 55.61% | 38.10% | Upgrade
|
| Operating Margin | -40.07% | -41.51% | -12.22% | -47.02% | -9.94% | Upgrade
|
| Profit Margin | -36.43% | -280.24% | -67.90% | -174.53% | 1.70% | Upgrade
|
| Free Cash Flow Margin | -21.40% | -34.73% | -16.18% | -32.68% | 4.22% | Upgrade
|
| EBITDA | -3.67 | -4.44 | -0.34 | -2.37 | 0.17 | Upgrade
|
| EBITDA Margin | -37.05% | -38.66% | -2.10% | -20.67% | 0.46% | Upgrade
|
| D&A For EBITDA | 0.3 | 0.33 | 1.66 | 3.02 | 3.77 | Upgrade
|
| EBIT | -3.97 | -4.77 | -2.01 | -5.38 | -3.6 | Upgrade
|
| EBIT Margin | -40.07% | -41.51% | -12.22% | -47.02% | -9.94% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 2.03% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.